Patents by Inventor Airo Tategaki
Airo Tategaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10675311Abstract: This invention provides lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect and that can be used with high safety. This invention further provides a pharmaceutical preparation comprising, as an active ingredient, lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect. According to the invention, novel lactic acid bacteria belonging to the Enterococcus faecium species having particular mycological properties and exhibiting viability of 40% or higher when freeze-dried in the absence of a dispersion medium and viability of 80% or higher in a probiotic preparation when stored at 40° C.Type: GrantFiled: July 7, 2016Date of Patent: June 9, 2020Assignee: KANEKA CORPORATIONInventors: Airo Tategaki, Taizo Kawabe, Hozumi Tanaka
-
Publication number: 20200060323Abstract: A food or a drink, including: Enterococcus faecium R30 strain (NITE BP-01362) or a processed product thereof; and at least one additive selected from the group consisting of a sweetener, a bittering agent, and acidulant. A method for promoting expression of PGC-1? protein, or preventing conversion of a slow twitch muscle into a fast twitch muscle, the method including: administering Enterococcus faecium R30 strain (NITE BP-01362) or a processed product thereof to a subject in need thereof.Type: ApplicationFiled: October 31, 2019Publication date: February 27, 2020Applicants: KANEKA CORPORATION, NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITYInventors: Hidemi FUJINO, Airo TATEGAKI
-
Publication number: 20190045819Abstract: A method for producing a fermented food composition by fermenting a food having a class-2 food allergen, includes: adding lactic acid bacteria having leucine aminopeptidase activity of 75 or more and 720 or less units, to a food having a class-2 food allergen, and fermenting the food while adjusting a pH of a mixture including the food to 4.0 or more and less than 8.5; and enzymatically treating the resulting mixture with a metalloprotease.Type: ApplicationFiled: September 28, 2016Publication date: February 14, 2019Applicant: KANEKA CORPORATIONInventors: Airo TATEGAKI, Hiroka MURAKAMI
-
Patent number: 9750775Abstract: The present invention provides very safe lactic acid bacteria and lactic acid bacteria preparations which are effective in prevention and therapy of allergies and/or in lowering of the blood neutral fat level. The present invention also provides pharmaceutical products and food or drink products which contain, as an active ingredient, a composition that contains cultured cells of the lactic acid bacterium Pediococcus acidilactici R037 or a treated product thereof.Type: GrantFiled: May 8, 2015Date of Patent: September 5, 2017Assignee: Kaneka CorporationInventors: Airo Tategaki, Toyoaki Watanabe, Kazuya Hamada
-
Patent number: 9737577Abstract: An object of the present invention is to provide a useful composition that contains a highly safe lactic acid bacterium or a component derived from this lactic acid bacterium. The present invention relates to a composition comprising at least one lactic acid bacterium selected from the group consisting of Lactobacillus delbrueckii subsp. lactis strain KR-037 (NITE BP-395), Lactobacillus delbrueckii subsp. lactis strain KLAB-4 (NITE BP-394), and variants thereof, or comprising a component derived from the lactic acid bacterium. The composition of the present invention is useful as a preparation that has an excellent antiallergic function and also has at least one other function selected from an anti-autoimmune disease function, a diabetes-improving function, a neutral fat-lowering function, and so forth.Type: GrantFiled: March 10, 2015Date of Patent: August 22, 2017Assignee: KANEKA CORPORATIONInventors: Airo Tategaki, Toyoaki Watanabe, Kazuya Hamada
-
Publication number: 20170232046Abstract: This invention provides lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect and that can be used with high safety. This invention further provides a pharmaceutical preparation comprising, as an active ingredient, lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect. According to the invention, novel lactic acid bacteria belonging to the Enterococcus faecium species having particular mycological properties and exhibiting viability of 40% or higher when freeze-dried in the absence of a dispersion medium and viability of 80% or higher in a probiotic preparation when stored at 40° C.Type: ApplicationFiled: July 7, 2016Publication date: August 17, 2017Applicant: KANEKA CORPORATIONInventors: Airo TATEGAKI, Taizo KAWABE, Hozumi TANAKA
-
Publication number: 20170027201Abstract: According to a manufacturing method of the present invention, Class 2 food allergens can be decomposed even if a protease is not used, and thus a manufacturing cost is inexpensive, and a food composition having a reduced content of Class 2 food allergens can be provided without using salt water which has an effect on the taste. The fermented food composition, obtained by the manufacturing method of the present invention, has a sufficiently reduced content of the Class 2 food allergens, and thus even those who contracts pollinosis or latex allergy can safely take it. The fermented food composition is tasty, and thus it can be used instead of food having the Class 2 food allergens.Type: ApplicationFiled: March 20, 2015Publication date: February 2, 2017Inventors: Airo TATEGAKI, Minoru UEDA
-
Publication number: 20150238547Abstract: The present invention provides very safe lactic acid bacteria and lactic acid bacteria preparations which are effective in prevention and therapy of allergies and/or in lowering of the blood neutral fat level. The present invention also provides pharmaceutical products and food or drink products which contain, as an active ingredient, a composition that contains cultured cells of the lactic acid bacterium Pediococcus acidilactici R037 or a treated product thereof.Type: ApplicationFiled: May 8, 2015Publication date: August 27, 2015Inventors: Airo Tategaki, Toyoaki Watanabe, Kazuya Hamada
-
Publication number: 20150182566Abstract: An object of the present invention is to provide a useful composition that contains a highly safe lactic acid bacterium or a component derived from this lactic acid bacterium. The present invention relates to a composition comprising at least one lactic acid bacterium selected from the group consisting of Lactobacillus delbrueckii subsp. lactis strain KR-037 (NITE BP-395), Lactobacillus delbrueckii subsp. lactis strain KLAB-4 (NITE BP-394), and variants thereof, or comprising a component derived from the lactic acid bacterium. The composition of the present invention is useful as a preparation that has an excellent antiallergic function and also has at least one other function selected from an anti-autoimmune disease function, a diabetes-improving function, a neutral fat-lowering function, and so forth.Type: ApplicationFiled: March 10, 2015Publication date: July 2, 2015Inventors: Airo Tategaki, Toyoaki Watanabe, Kazuya Hamada
-
Publication number: 20150139970Abstract: This invention provides lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect and that can be used with high safety. This invention further provides a pharmaceutical preparation comprising, as an active ingredient, lactic acid bacteria that have one or more effects selected from among fatigue-ameliorating effect, blood circulation-improving effect, stool odor-reducing effect, and growth-promoting effect. According to the invention, novel lactic acid bacteria belonging to the Enterococcus faecium species having particular mycological properties and exhibiting viability of 40% or higher when freeze-dried in the absence of a dispersion medium and viability of 80% or higher in a probiotic preparation when stored at 40° C.Type: ApplicationFiled: February 2, 2015Publication date: May 21, 2015Applicant: KANEKA CORPORATIONInventors: Airo TATEGAKI, Taizo Kawabe, Hozumi Tanaka
-
Publication number: 20130058898Abstract: The present invention provides very safe lactic acid bacteria and lactic acid bacteria preparations which are effective in prevention and therapy of allergies and/or in lowering of the blood neutral fat level. The present invention also provides pharmaceutical products and food or drink products which contain, as an active ingredient, a composition that contains cultured cells of the lactic acid bacterium Pediococcus acidilactici R037 or a treated product thereof.Type: ApplicationFiled: March 9, 2011Publication date: March 7, 2013Applicant: KANEKA CORPORATIONInventors: Airo Tategaki, Toyoaki Watanabe, Kazuya Hamada
-
Publication number: 20100278795Abstract: An object of the present invention is to provide a useful composition that contains a highly safe lactic acid bacterium or a component derived from this lactic acid bacterium. The present invention relates to a composition comprising at least one lactic acid bacterium selected from the group consisting of Lactobacillus delbrueckii subsp. lactis strain KR-037 (NITE BP-395), Lactobacillus delbrueckii subsp. lactis strain KLAB-4 (NITE BP-394), and variants thereof, or comprising a component derived from the lactic acid bacterium. The composition of the present invention is useful as a preparation that has an excellent antiallergic function and also has at least one other function selected from an anti-autoimmune disease function, a diabetes-improving function, a neutral fat-lowering function, and so forth.Type: ApplicationFiled: November 19, 2008Publication date: November 4, 2010Applicant: Kaneka CorporationInventors: Airo Tategaki, Toyoki Watanabe, Kazuya Hamada